Publications

@article{Yerbanga2023,

title = {Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review},

author = {Isidore W. Yerbanga and Seydou Nakanabo Diallo and Toussaint Rouamba and Agustin Resendiz-Sharpe and Katrien Lagrou and Olivier Denis and Hector Rodriguez-Villalobos and Isabel Montesinos and Sanata Bamba},

url = {https://pubmed.ncbi.nlm.nih.gov/37603962/},

doi = {10.1016/J.MYCMED.2023.101413},

issn = {1773-0449},

year  = {2023},

date = {2023-01-01},

journal = {Journal de mycologie medicale},

volume = {33},

issue = {4},

publisher = {J Mycol Med},

abstract = {The therapeutic management of invasive aspergillosis should be guided by antifungal susceptibility testing (AFST). The disk diffusion (DD) method due to its simplicity and low cost could be an appropriate alternative to the reference methods (CLSI, EUCAST) which are not suitable for AFST in routine clinical microbiology laboratories, particularly in resource-constrained settings. This review summarizes the available data on the performance of the DD method in determining triazole susceptibility profile of Aspergillus species. The published articles on the performance of DD method for determining triazole susceptibility of Aspergillus spp. were systematically searched on major medical databases and Google Scholar. We identified 2725 articles of which 13 met the inclusion criteria. The overall average agreement value obtained between DD and CLSI broth microdilution (CLSI-BMD) methods for the itraconazole 10 µg disk (70.75%) was low especially when the medium used was not Mueller-Hinton (MH) agar. In contrast average agreement for the voriconazole 1 µg disk and the posaconazole 5 µg disk were \> 94% regardless of media used. The correlation coefficient values between the DD and CLSI-BMD methods on MH agar were acceptable (≥ 0.71) for the itraconazole 10 µg disk and posaconazole 5 µg disk and good (≥ 0.80) for the voriconazole 1 and 10 µg disk. The reproducibility of the DD method regardless to the medium used was ≥ 82%. This systematic review shows that the disk diffusion method could be a real alternative for triazole antifungals susceptibility testing of Aspergillus spp.},

keywords = {Agar, Antifungal Agents* / pharmacology, Aspergillus, doi:10.1016/j.mycmed.2023.101413, Isidore W Yerbanga, Itraconazole* / pharmacology, MEDLINE, Microbial Sensitivity Tests, National Center for Biotechnology Information, National Institutes of Health, National Library of Medicine, NCBI, NIH, NLM, pmid:37603962, PubMed Abstract, Reproducibility of Results, Review, Sanata Bamba, Seydou Nakanabo Diallo, Systematic review, Triazoles / pharmacology, Voriconazole / pharmacology},

pubstate = {published},

tppubtype = {article}

}

@article{Garba2023,

title = {Wastewater from healthcare centers in Burkina Faso is a source of ESBL, AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae},

author = {Zakaria Garba and Isidore O. J. Bonkoungou and Nad\`{e}ge O. Millogo and H. Magloire Natama and Pingdwend\'{e} A. P. Vokouma and Massa A. Bonko and Ibrahima Karama and Lagm\^{e}yesgo A. W. Tiendrebeogo and Kaisa Haukka and Halidou Tinto and Lassana Sangar\'{e} and Nicolas Barro},

url = {https://pubmed.ncbi.nlm.nih.gov/37978428/},

doi = {10.1186/S12866-023-03108-0},

issn = {1471-2180},

year  = {2023},

date = {2023-01-01},

journal = {BMC microbiology},

volume = {23},

issue = {1},

publisher = {BMC Microbiol},

abstract = {Background: Extended-spectrum β-lactamase (ESBL), plasmid-mediated AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae have spread into the environment worldwide posing a potential public health threat. However, the prevalence data for low- and middle-income countries are still scarce. The aim of this study was to evaluate the presence of ESBL, AmpC-β-lactamase and carbapenemase-producing and multidrug-resistant E. coli and K. pneumoniae in wastewaters from healthcare centers in Burkina Faso. Results: Eighty-four (84) wastewater samples were collected from five healthcare centers and plated on selective ESBL ChromAgar. E. coli and Klebsiella pneumoniae isolates were identified using API20E. ESBL-producing bacteria were detected in 97.6% of the samples and their average concentration per hospital ranged from 1.10 × 105 to 5.23 × 106 CFU/mL. Out of 170 putative ESBL-producing isolates (64% of them were E. coli) and 51 putative AmpC-β-lactamase-producing isolates, 95% and 45% were confirmed, respectively. Carbapenemase production was detected in 10 isolates, of which 6 were NDM producers, 3 were OXA-48 producers and 1 was NDM and OXA-48 producer. All isolates were multidrug resistant and, moreover, all of them were resistant to all tested β-lactams. Resistance to ESBL inhibitors was also common, up to 66% in E. coli and 62% in K. pneumoniae. Amikacin, fosfomycin and nitrofurantoin were the antibiotics to which the least resistance was detected. Conclusions: This study showed that wastewater from healthcare centers constitutes a reservoir of multidrug-resistant bacteria in Burkina Faso, including carbapenemase producers. Untreated healthcare wastewater entering the environment exposes people and animals to infections caused by these multi-resistant bacteria, which are difficult to treat, especially in the resource-poor settings.},

keywords = {Animals, Anti-Bacterial Agents / pharmacology, bacteria, Bacterial Proteins, beta-Lactamases, Burkina Faso, Carbapenem-Resistant Enterobacteriaceae*, doi:10.1186/s12866-023-03108-0, Escherichia coli, Escherichia coli Infections* / microbiology, Humans, Isidore O J Bonkoungou, Klebsiella pneumoniae, MEDLINE, Microbial Sensitivity Tests, National Center for Biotechnology Information, National Institutes of Health, National Library of Medicine, NCBI, Nicolas Barro, NIH, NLM, Non-U.S. Gov't, PMC10655474, pmid:37978428, PubMed Abstract, Research Support, Wastewater, Zakaria Garba},

pubstate = {published},

tppubtype = {article}

}